Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Perspective Therapeutics (CATX) over the last 10 years, with Q3 2025 value amounting to 428.63.

  • Perspective Therapeutics' Interest Coverage Ratio fell 5871.81% to 428.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 496.72, marking a year-over-year decrease of 2509.01%. This contributed to the annual value of 1893.46 for FY2024, which is 27923.74% down from last year.
  • Perspective Therapeutics' Interest Coverage Ratio amounted to 428.63 in Q3 2025, which was down 5871.81% from 202.01 recorded in Q2 2025.
  • Perspective Therapeutics' Interest Coverage Ratio's 5-year high stood at 616.22 during Q4 2024, with a 5-year trough of 696.43 in Q3 2023.
  • Its 3-year average for Interest Coverage Ratio is 329.45, with a median of 428.63 in 2025.
  • The largest annual percentage gain for Perspective Therapeutics' Interest Coverage Ratio in the last 5 years was 22666.38% (2024), contrasted with its biggest fall of 6530.03% (2024).
  • Perspective Therapeutics' Interest Coverage Ratio (Quarter) stood at 486.5 in 2023, then surged by 226.66% to 616.22 in 2024, then crashed by 169.56% to 428.63 in 2025.
  • Its last three reported values are 428.63 in Q3 2025, 202.01 for Q2 2025, and 170.56 during Q1 2025.